Coverage
-
March 13, 2018
Illumina Inc. urged the Federal Circuit to pass on Ariosa Diagnostics Inc.'s bid for a rehearing of an affirmed Patent Trial and Appeal Board decision in the companies' long-running feud over prenatal testing technology, arguing there was nothing "exceptionally important" about the panel's ruling.
2 other articles on this case.
View all »